相似文献
1
Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis.
J Epidemiol Community Health. 1992 Oct;46(5):517-8. doi: 10.1136/jech.46.5.517.
2
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies.
Neuroepidemiology. 2004 Jan-Apr;23(1-2):73-7. doi: 10.1159/000073978.
3
Validity of death certificates in the identification of cases of amyotrophic lateral sclerosis (ALS) in the Limousin region, France. A population-based study.
Amyotroph Lateral Scler Frontotemporal Degener. 2020 May;21(3-4):228-234. doi: 10.1080/21678421.2020.1746811. Epub 2020 Apr 10.
4
The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy.
Amyotroph Lateral Scler. 2008 Dec;9(6):350-3. doi: 10.1080/17482960802196150.
5
[Causes of death in amyotrophic lateral sclerosis : Results from the Rhineland-Palatinate ALS registry].
Nervenarzt. 2017 Aug;88(8):911-918. doi: 10.1007/s00115-017-0293-3.
6
Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS Surveillance Pilot Project.
Amyotroph Lateral Scler. 2012 Jan;13(1):69-73. doi: 10.3109/17482968.2011.614253. Epub 2011 Sep 19.
7
Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers.
Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):303-310. doi: 10.1080/21678421.2017.1418004. Epub 2017 Dec 22.
8
Validating population-based registers for ALS: how accurate is death certification?
J Neurol. 2010 Aug;257(8):1235-9. doi: 10.1007/s00415-010-5494-7. Epub 2010 Feb 12.
9
Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):224-9. doi: 10.3109/21678421.2014.988161. Epub 2015 May 6.
10
Is firstly diagnosed ALS really ALS? Results of a population-based study with long-term follow-up.
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):221-226. doi: 10.1080/21678421.2016.1249886. Epub 2016 Nov 28.
引用本文的文献
1
A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.
Neurol Sci. 2022 Dec;43(12):6667-6691. doi: 10.1007/s10072-022-06319-x. Epub 2022 Aug 17.
2
Systematic literature review of the epidemiology of glyphosate and neurological outcomes.
Int Arch Occup Environ Health. 2023 Jan;96(1):1-26. doi: 10.1007/s00420-022-01878-0. Epub 2022 May 23.
3
Contact Sports as a Risk Factor for Amyotrophic Lateral Sclerosis: A Systematic Review.
Global Spine J. 2019 Feb;9(1):104-118. doi: 10.1177/2192568218813916. Epub 2019 Jan 31.
4
Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies.
Eur J Neurol. 2019 Mar;26(3):468-475. doi: 10.1111/ene.13840. Epub 2018 Nov 9.
5
Increase in assisted suicide in Switzerland: did the socioeconomic predictors change? Results from the Swiss National Cohort.
BMJ Open. 2018 Apr 17;8(4):e020992. doi: 10.1136/bmjopen-2017-020992.
6
Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: A systematic review.
PLoS One. 2017 Feb 28;12(2):e0172639. doi: 10.1371/journal.pone.0172639. eCollection 2017.
7
Population-based risks for cancer in patients with ALS.
Neurology. 2016 Jul 19;87(3):289-94. doi: 10.1212/WNL.0000000000002757. Epub 2016 May 11.
8
Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort.
Epidemiology. 2015 Nov;26(6):831-8. doi: 10.1097/EDE.0000000000000376.
9
Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.
PLoS One. 2015 Jul 14;10(7):e0131965. doi: 10.1371/journal.pone.0131965. eCollection 2015.
10
Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):224-9. doi: 10.3109/21678421.2014.988161. Epub 2015 May 6.
本文引用的文献
1
Motor neuron disease in England and Wales, 1959-1979.
J Neurol Neurosurg Psychiatry. 1983 Mar;46(3):197-205. doi: 10.1136/jnnp.46.3.197.
2
Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population.
J Neurol Sci. 1984 Nov-Dec;66(2-3):165-73. doi: 10.1016/0022-510x(84)90004-2.
3
The reliability of death certificate reporting for amyotrophic lateral sclerosis.
J Chronic Dis. 1971 Jun;24(1):5-8. doi: 10.1016/0021-9681(71)90053-1.
4
Multiple sclerosis and motor neurone disease: survival and how certified after death.
J Epidemiol Community Health. 1987 Mar;41(1):14-7. doi: 10.1136/jech.41.1.14.
5
Increasing trend of ALS in France and elsewhere: are the changes real?
Neurology. 1989 Jun;39(6):768-73. doi: 10.1212/wnl.39.6.768.
6
Rising mortality from motoneuron disease in the USA, 1962-84.
Lancet. 1989 Apr 1;1(8640):710-3. doi: 10.1016/s0140-6736(89)92218-6.
7
The mortality of motor neuron disease in Sweden.
Arch Neurol. 1990 Jan;47(1):42-6. doi: 10.1001/archneur.1990.00530010050018.
8
Amyotrophic lateral sclerosis in Finland. I: An epidemiologic study.
Acta Neurol Scand. 1977 Sep;56(3):185-93. doi: 10.1111/j.1600-0404.1977.tb01424.x.
9
Changing mortality patterns of motor neuron disease in Japan.
J Neurol Sci. 1977 Jul;32(3):411-24. doi: 10.1016/0022-510x(77)90023-5.
Zotero 插件